Deutsche Bank Begins Coverage on Cardinal Health (CAH)

Deutsche Bank initiated coverage on shares of Cardinal Health (NYSE:CAH) in a research note published on Monday morning, Marketbeat reports. The firm issued a hold rating and a $64.00 price objective on the stock.

Several other research firms also recently commented on CAH. UBS reiterated a neutral rating and set a $76.00 price objective (down from $79.00) on shares of Cardinal Health in a research note on Wednesday, August 9th. Zacks Investment Research downgraded shares of Cardinal Health from a hold rating to a sell rating in a research note on Monday, August 7th. Needham & Company LLC reiterated a hold rating on shares of Cardinal Health in a research note on Sunday, September 10th. Robert W. Baird reissued a hold rating and set a $73.00 target price on shares of Cardinal Health in a report on Sunday, September 17th. Finally, Royal Bank Of Canada assumed coverage on shares of Cardinal Health in a report on Tuesday, September 19th. They set a sector perform rating and a $72.00 target price for the company. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of $73.91.

Shares of Cardinal Health (NYSE:CAH) opened at $59.72 on Monday. Cardinal Health has a one year low of $54.66 and a one year high of $84.88. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35. The company has a market cap of $18,986.33, a price-to-earnings ratio of 11.45, a PEG ratio of 1.75 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.09. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business had revenue of $32.64 billion during the quarter, compared to the consensus estimate of $33.48 billion. During the same period in the previous year, the firm posted $1.24 earnings per share. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. research analysts predict that Cardinal Health will post 4.97 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 3.10%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.78%.

Several institutional investors have recently modified their holdings of CAH. Franklin Resources Inc. increased its holdings in Cardinal Health by 72.1% in the second quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock valued at $489,613,000 after buying an additional 2,632,836 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in Cardinal Health by 71.4% in the second quarter. Ameriprise Financial Inc. now owns 3,557,123 shares of the company’s stock valued at $277,191,000 after buying an additional 1,482,285 shares in the last quarter. BlackRock Inc. increased its holdings in Cardinal Health by 6.5% in the second quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock valued at $1,779,958,000 after buying an additional 1,398,496 shares in the last quarter. American Century Companies Inc. increased its holdings in Cardinal Health by 58.7% in the third quarter. American Century Companies Inc. now owns 2,976,776 shares of the company’s stock valued at $199,206,000 after buying an additional 1,100,507 shares in the last quarter. Finally, HealthCor Management L.P. purchased a new position in Cardinal Health in the second quarter valued at $84,496,000. 88.47% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.com-unik.info/2017/12/07/deutsche-bank-begins-coverage-on-cardinal-health-cah.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

What are top analysts saying about Cardinal Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardinal Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit